Open Demo Account
Home / Market Update / Global Stock Market / European Shares Rise, AstraZeneca Plummet Due to Halting Coronavirus Vaccine Trials

European Shares Rise, AstraZeneca Plummet Due to Halting Coronavirus Vaccine Trials

Adel 9 September, 2020 1:50 pm Global Stock Market, Market Update

European shares stabilized on Wednesday after falling sharply in the previous session, but sentiment was shaken by the suspension of AstraZeneca global trials of its Covid-19 vaccine.

AstraZeneca shares fell 1.3% as it announced the suspension of large trials in its final stages on an experimental vaccine due to the illness of one of the participants in the study without knowing the cause.

The European Stoxx600 index rose 0.1% by 07:10 GMT, while travel and entertainment stocks were among the biggest decliners in early trade.

Tags

Check Also

U.S. Stock Futures Rise, Capping Strong First Half, Ahead of Key Inflation Data

U.S. stock index futures climbed on Friday, marking a robust first half of the year, …

This site contains information and opinions for the purpose of providing only general information and can not be relied upon. The information and opinions contained in this Site shall in no way constitute an offer or solicitation to buy, sell or subscribe to any investment product. Users of this site shall bear any risks arising from the use of any information, opinion, program, service or material. Noor Trends reserves the right to make any change to the Site, the information, opinions, materials, products, programs, services or prices (if any) at any time without notice.
All copyrights reserved Noor Trends